Harmony Biosciences' Wakix shows promise for significant revenue growth. Find out why HRMY stock’s profitability and pipeline ...
Rheumatoid arthritis is the most common inflammatory joint disorder, affecting over 60,000 people in Austria alone, with women being three times as ...
Governor of the Central Bank of Sri Lanka Dr. Nandalal Weerasinghe has said combating money laundering and countering financing of terrorism will help improve the credibility of the financial system, ...
Researchers at CeMM and the Medical University of Vienna have developed an innovative microscopy-based approach that could ...
Phosphoproteomics unveils the mode of action of clinical ATR inhibitors and explains their synergy with Gemcitabine in ...
Physician empathy has long been recommended — but not required — in the doctor-patient relationship.However, for a growing ...
Ticiana Leal, MD, discussed the case of a 73-Year-Old woman with progressive extensive-stage small cell lung cancer.
The FDA has approved Cobenfy, a new drug to treat people with schizophrenia that comes with fewer side effects.
Xenon has promising Phase 2 data for MDD treatment, robust financials, and a potential in niche markets, despite premium ...
The FDA continues its regulation pronouncement streak, changing its authorization of Red No. 3 days ahead of the incoming ...
The FDA announced a ban on the controversial red dye no. 3, which gives food and drinks a bright, cherry red color and has ...
The proportion of obese Indians has risen from 25 per cent in 2013 to 40 per cent in 2023, highlighting the need for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback